635751-42-7

Basic information

• Product Name: 2-[Cyclohexyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl]-1H-benzimidazol-1-yl]carbonyl]amino]ethyl ethyl carbonate
• Synonyms: 2-[Cyclohexyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl]-1H-benzimidazol-1-yl]carbonyl]amino]ethyl ethyl carbonate
• CAS NO: 635751-42-7
• Molecular Weight: 610.654
• Mol File: 635751-42-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-[Cyclohexyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl]-1H-benzimidazol-1-yl]carbonyl]amino]ethyl ethyl carbonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[Cyclohexyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl]-1H-benzimidazol-1-yl]carbonyl]amino]ethyl ethyl carbonate(635751-42-7)
• EPA Substance Registry System: 2-[Cyclohexyl[[(R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfinyl]-1H-benzimidazol-1-yl]carbonyl]amino]ethyl ethyl carbonate(635751-42-7)

Safety Data

• Hazardous Substances Data: 635751-42-7(Hazardous Substances Data)

Upstream product

• 2842-38-8 cyclohexyl(2-(hydroxy)ethyl)amine 
• 479028-31-4 tert-butyl cyclohexyl(2-hydroxyethyl)carbamate 
• 635750-93-5 2-(cyclohexylamino)ethyl ethyl carbonate hydrochloride 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 138530-94-6 (R)-lansoprazole 

Relevant articles and documents

CONTROLLED RELEASE PREPARATION

A controlled release preparation wherein the release of active ingredient is controlled, which releases an active ingredient for an extended period of time by staying or slowly migrating in the gastrointestinal tract, is provided by means such as capsulating a tablet, granule or fine granule wherein the release of active ingredient is controlled and a gel-forming polymer. Said tablet, granule or fine granule has a release-controlled coating-layer formed on a core particle containing an active ingredient.

DRUG COMPOSITION HAVING ACTIVE INGREDIENT ADHERED AT HIGH CONCENTRATION TO SPHERICAL CORE

Granule, fine particle or tablet of excellent leaching property, comprising a drug active ingredient in high content realized by forming a layer containing drug active ingredient on core particles through a combination of a method of dispersing and adhering an active ingredient while spraying or adding a binder with a method of spraying or adding a solution or suspension wherein an active ingredient and a binder are contained so as to effect adhesion. Further, there are provided a drug composition containing such a granule, fine particle or tablet and a process for producing the same.